Opioid overdoses are responsible for over 40,000 deaths per year in the United States alone as the opioid epidemic becomes more critical. The opioid-blocking medication Narcan has been around for a while and is considered the go-to for those experiencing an opiate overdose. However, two brand-new drugs have recently been approved by the FDA and
A research study recently released by NIDA (the National Institute on Drug Abuse) found that improvised medical devices that deliver naloxone intranasally are significantly less effective when it comes to administering high enough doses of the opioid-antagonist drug. Narcan injections and FDA-approved nasal naloxone, the research shows, tend to apply the correct dosages correctly more
Teleflex Medical, the manufacturer of the nasal naloxone kits used by first responders and others nationwide to reverse overdoses from heroin and prescription painkillers, has issued a nationwide recall. Why is the Nasal Naloxone Kit Under Recall? The recall, announced earlier this week, affects the atomizers only, which are used to administer the drug as
